Evidence has been cited previously that an estimated 30 percent of hysterectomies currently being performed in the united states today can be considered 'elective' in the sense that sterilization or prevention of endometrial and cervical cancers or other nonmedical indications dominate the decision for a woman to undergo a hyste- rectomy. None of the quantitative analysis of risks, costs and bene- fits of hysterectomies has found hysterectomies to be cost effective for sterilization or prevention of uterine cancer. If risks and savings are discounted, even at very low rates of 2 to 3 percent, any monetary savings or increased life expectancy achievedby hyste- rectomy becomes offset by the monetary costs and immediate health risks of the operation.